Myelodysplastic syndromes current treatment algorithm 2018

por Steensma, David P.
Publicado 2018

Dr Li Wenliang: Wuhan “Whistleblower” and Early COVID-19 Victim

por Steensma, David P., Kyle, Robert A.
Publicado 2022

Austria’s Unusual Pandemic-Themed Postage Stamps: Toilet Paper, Facemask, Bandage

por Steensma, David P., Kyle, Robert A.
Publicado 2022

Historical expectations with DNA methyltransferase inhibitor monotherapy in MDS: when is combination therapy truly “promising”?

por Brunner, Andrew M., Fell, Geoffrey, Steensma, David P.
Publicado 2022

Selection of patients with myelodysplastic syndromes from a large electronic medical records database and a study of the use of disease-modifying therapy in the United States

por Ma, Xiaomei, Steensma, David P, Scott, Bart L, Kiselev, Pavel, Sugrue, Mary M, Swern, Arlene S
Publicado 2018

Oncologists’ Reluctance to Use the Terms Hope and Cure: A Bibliometric Analysis of Articles From Two High-Impact Oncology Journals

por Corn, Benjamin W, Feldman, David, Schapira, Lidia, Steensma, David P, Loprinzi, Charles L, Bian, Jiang
Publicado 2020

P1339: IMPACT OF CLONAL HEMATOPOIESIS AND CANAKINUMAB ON NON-HEMATOLOGICAL MALIGNANCY: ANALYSIS OF THE CANTOS RANDOMIZED CLINICAL TRIAL

por Woo, Janghee, Zhai, Tingting, Yang, Fang, Xu, Huilei, Healey, Margaret, Yates, Denise P., Beste, Michael T., Steensma, David P.
Publicado 2023

Genomic alterations in patients with somatic loss of the Y chromosome as the sole cytogenetic finding in bone marrow cells

por Ouseph, Madhu M., Hasserjian, Robert P., Dal Cin, Paola, Lovitch, Scott B., Steensma, David P., Nardi, Valentina, Weinberg, Olga K.
Publicado 2020

Phase 1 dose-ranging study of ezatiostat hydrochloride in combination with lenalidomide in patients with non-deletion (5q) low to intermediate-1 risk myelodysplastic syndrome (MDS)

por Raza, Azra, Galili, Naomi, Mulford, Deborah, Smith, Scott E, Brown, Gail L, Steensma, David P, Lyons, Roger M, Boccia, Ralph, Sekeres, Mikkael A, Garcia-Manero, Guillermo, Mesa, Ruben A
Publicado 2012

Adverse Event Reporting in Randomized Clinical Trials for Multiple Myeloma

por Najjar, Mimi, McCarron, John, Cliff, Edward R. Scheffer, Berger, Katherine, Steensma, David P., Al Hadidi, Samer, Chakraborty, Rajshekhar, Goodman, Aaron, Anto, Eric, Greene, Tom, Sborov, Douglas, Mohyuddin, Ghulam Rehman
Publicado 2023

Validation of International Working Group response criteria in higher‐risk myelodysplastic syndromes: A report on behalf of the MDS Clinical Research Consortium

por Komrokji, Rami S., Al Ali, Najla H, Sallman, David, Padron, Eric, DeZern, Amy E., Barnard, John, Roboz, Gail J., Garcia‐Manero, Guillermo, List, Alan, Steensma, David P., Sekeres, Mikkael A.
Publicado 2020

Blockade of IL-22 signaling reverses erythroid dysfunction in stress-induced anemias

por Raundhal, Mahesh, Ghosh, Shrestha, Myers, Samuel A., Cuoco, Michael S., Singer, Meromit, Carr, Steven A., Waikar, Sushrut S., Bonventre, Joseph V., Ritz, Jerome, Stone, Richard M., Steensma, David P., Regev, Aviv, Glimcher, Laurie H.
Publicado 2021

Validation of a post-hypomethylating agent failure prognostic model in myelodysplastic syndromes patients treated in a randomized controlled phase III trial of rigosertib vs. best...

por Nazha, Aziz, Sekeres, Mikkael A., Komrokji, Rami, Steensma, David P., Kantarjian, Hagop, Roboz, Gail, Fenaux, Pierre, Prebet, Thomas, Azarnia, Nozar, Zbyszewski, Patrick S., Fruchtman, Steven M., Santini, Valeria, Silverman, Lewis R., Platzbecker, Uwe, Garcia-Manero, Guillermo
Publicado 2017

Fit Older Adults with Advanced Myelodysplastic Syndromes: Who is Most Likely to Benefit from Transplant?

por Abel, Gregory A., Kim, Haesook T., Hantel, Andrew, Steensma, David P., Stone, Richard, Habib, Anand, Ho, Vincent T., Wadleigh, Martha, El-Jawahri, Areej, Alyea, Edwin P., DeAngelo, Daniel, Koreth, John, Antin, Joseph H., Soiffer, Robert J., Cutler, Corey
Publicado 2020

Genomic Biomarkers to Predict Resistance to Hypomethylating Agents in Patients With Myelodysplastic Syndromes Using Artificial Intelligence

por Nazha, Aziz, Sekeres, Mikkael A., Bejar, Rafael, Rauh, Michael J., Othus, Megan, Komrokji, Rami S., Barnard, John, Hilton, Cameron B., Kerr, Cassandra M., Steensma, David P., DeZern, Amy, Roboz, Gail, Garcia-Manero, Guillermo, Erba, Harry, Ebert, Benjamin L., Maciejewski, Jaroslaw P.
Publicado 2019

Clonal hematopoiesis is associated with increased risk of progression of asymptomatic Waldenström macroglobulinemia

por Tahri, Sabrin, Mouhieddine, Tarek H., Redd, Robert, Lampe, Luisa, Nilsson, Katarina I., El-Khoury, Habib, Su, Nang Kham, Nassar, Amin H., Adib, Elio, Bindra, Govind, Abou Alaiwi, Sarah, Trippa, Lorenzo, Steensma, David P., Castillo, Jorge J., Treon, Steven P., Ghobrial, Irene M., Sperling, Adam S.
Publicado 2022

Patient‐Clinician Discordance in Perceptions of Treatment Risks and Benefits in Older Patients with Acute Myeloid Leukemia

por El‐Jawahri, Areej, Nelson‐Lowe, Margaret, VanDusen, Harry, Traeger, Lara, Abel, Gregory A., Greer, Joseph A., Fathi, Amir, Steensma, David P., LeBlanc, Thomas W., Li, Zhigang, DeAngelo, Daniel, Wadleigh, Martha, Hobbs, Gabriela, Foster, Julia, Brunner, Andrew, Amrein, Philip, Stone, Richard M., Temel, Jennifer S.
Publicado 2018

Connect MDS/AML: design of the myelodysplastic syndromes and acute myeloid leukemia disease registry, a prospective observational cohort study

por Steensma, David P., Abedi, Medrdad, Bejar, Rafael, Cogle, Christopher R., Foucar, Kathryn, Garcia-Manero, Guillermo, George, Tracy I., Grinblatt, David, Komrokji, Rami, Ma, Xiaomei, Maciejewski, Jaroslaw, Pollyea, Daniel A., Savona, Michael R., Scott, Bart, Sekeres, Mikkael A., Thompson, Michael A., Swern, Arlene S., Nifenecker, Melissa, Sugrue, Mary M., Erba, Harry
Publicado 2016

Eprenetapopt (APR-246) and Azacitidine in TP53-Mutant Myelodysplastic Syndromes

por Sallman, David A., DeZern, Amy E., Garcia-Manero, Guillermo, Steensma, David P., Roboz, Gail J., Sekeres, Mikkael A., Cluzeau, Thomas, Sweet, Kendra L., McLemore, Amy, McGraw, Kathy L., Puskas, John, Zhang, Ling, Yao, Jiqiang, Mo, Qianxing, Nardelli, Lisa, Al Ali, Najla H., Padron, Eric, Korbel, Greg, Attar, Eyal C., Kantarjian, Hagop M., Lancet, Jeffrey E., Fenaux, Pierre, List, Alan F., Komrokji, Rami S.
Publicado 2021

Real‐world diagnostic testing patterns for assessment of ring sideroblasts and SF3B1 mutations in patients with newly diagnosed lower‐risk myelodysplastic syndromes

por Patel, Jay L., Abedi, Mehrdad, Cogle, Christopher R., Erba, Harry P., Foucar, Kathryn, Garcia‐Manero, Guillermo, Grinblatt, David L., Komrokji, Rami S., Kurtin, Sandra E., Maciejewski, Jaroslaw P., Pollyea, Daniel A., Revicki, Dennis A., Roboz, Gail J., Savona, Michael R., Scott, Bart L., Sekeres, Mikkael A., Steensma, David P., Thompson, Michael A., Dawn Flick, Elizabeth, Kiselev, Pavel, Louis, Chrystal U., Nifenecker, Melissa, Swern, Arlene S., George, Tracy I.
Publicado 2020